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Abstract  
 
Vascular endothelial growth factor receptor-2 (VEGFR-2) is attractive target for the development of 
novel anticancer agents. In this work quantitative structure-activity relationship (QSAR) study was 
performed to understand the inhibitory activity of a set of 192 VEGFR-2 compounds. While we 
chose those compounds we didn’t depend on some core or some compound derivatives, we chose 
varied compounds and that is to get a comprehensive model can be applied on a large number of 
compounds.  QSAR models were developed using multiple linear regression (MLR) and partial 
least squares (PLS) as linear methods. While principal component - artificial neural networks (PC-
ANN) modeling method was used as nonlinear method. The results obtained offer good regression 
models having good prediction ability. The results obtained by MLR and PLS are close and better 
than those obtained by principal component- artificial neural network. The best MLR model was 
obtained with a correlation coefficient of 0.870, and the correlation coefficient value of the best 
PLS model is 0.860, while the correlation coefficient value of the best PC-ANN model is 0.752. 
The strength and the predictive performance of the proposed models was verified using both 
internal (cross-validation and Y-scrambling) and external statistical validations. 
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1.1 Angiogenesis:  
1.1.1 Definition:  
Angiogenesis is one of the most pervasive and fundamentally essential biological processes 
encountered in mammalian organisms. (1) It is the process of blood vessel sprouting and 
generating new capillaries from existing vasculature, and an important event in a variety of 
physiological processes including ovulation, embryonic development, wound repair and 
collateral generation in the myocardium. Angiogenesis is tightly regulated in both time and 
space. It is driven by a cocktail of growth factors and proangiogenic cytokines and tempered 
by an equally diverse group of inhibitors of neovascularization. (2) 
There are  number of key steps in the angiogenic cascade including the reactivation of 
endothelial cells (EC), rupture of basement membrane (BM), adhesion, migration, 
proliferation, table formation, and sprouting of new capillary blood vessels of preexisting 
vessels. The rate of basement membrane(BM) synthesis has been shown to directly correlate
with the formation of new blood vessels. Several studies suggested that different BM play a 
pivotal role in angiogenesis. BM is not only an essential element of all blood vessels, but it 
also plays the roleof a local hormone for activated EC. In that regard, BM biosynthesis might 
represent an ideal targetfor developing suppressors of angiogenesis. (1) 
In adult organs, the turnover of EC is an extremely slow process, which accelerates only in a 
few physiological situations such as embryogenesis, ovulation, and wound healing. Under 
these special circumstances angiogenesis lasts for a relatively short time (days-weeks) then 
return to a quiescent state in a self limited and well regulated both temporally and spatially 
through a well coordinated and balanced angiosuppressors and angiopromoters. In contrast, 
pathological angiogenesis can last for years and somewhat out of control due to unrestricted 
production of normal or aberrant forms of proangiogenic mediators and /or the result of a 
relative deficiency in angiogenic inhibitory molecules. This can result in various forms of 
pathological angiogenesis including: (1) 

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1.Ocular neovascularization-mediated diseases: diabetic retinopathy (retinal 
neovascularization) and age-related macular degeneration (choroidal neovascularization), DR 
& AMD, respectively. 
2. Cancer: metastasis of solid tumor. 
3. Chronic inflammatory disorders: rheumatoid arthritis (RA), psoriasis. 
4. Vascular diseases—ischemic heart diseases, atherosclerosis. 
Hence understanding the mechanisms involved in the regulation of angiogenesis could have a 
major impact in the prevention and treatment of pathological angiogenesis processes. 
1.1.2 Regulation of Angiogenesis 
The organ microenvironment controls the extent of vascularization under physiological and 
pathological conditions. It has been demonstrated that in tissues, Vascular endothelial growth 
factor (VEGF) and corresponding receptors VEGFR-1 (Flt-1) and VEGFR-2 [kinase insert 
domain receptor (KDR)] are critical regulators of angiogenesis and that specific binding of 
VEGF to VEGFR-2 would initiate effective downstream cell proliferation signaling pathways 
and even leads to tumor vascularization, which promotes tumor infiltration and metastasis. (3) 
Conversely, inhibition of VEGF action by specific monoclonal antibodies or soluble receptors 
results in suppression of neovascularization associated with tumors and retinopathies. 
Endothelial cells play a major role in the modeling of blood vessels. The interplay of growth 
factors, cell adhesion molecules and specific signal transduction pathways either in the 
maintenance of the quiescent state or in the reactivation of endothelial cells is well 
coordinated. (1) 
Vascular Endothelial Growth Factor (VEGF): 
It is a member of angiogenic mediators that act directly on the EC .VEGF is a potent mitogen 
and angiogenesis-promoting factor in vivo. VEGF has been shown to be secreted in response 
to hypoxic or ischemic insults with the subsequent initiation and amplification of 
neovascularization. VEGF appears to be a crucial mediator of blood vessel growth associated 
with tumors and proliferative retinopathies. Strong experimental evidence indicates that VEGF 

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is a major mediator of angiogenesis associated with most human tumors and also ischemic 
retinal disorders. (2) 
Anti-VEGF monoclonal antibodies or soluble receptors suppress neovascularization in a 
variety of animal models. Therefore, a humanized anti-VEGF antibody has therapeutic value 
for a variety of disorders where angiogenesis plays a significant role.(1) 
Tyrosine Kinases 
Two tyrosine kinases have been identified as putative VEGF receptors including VEGFR-1 
(Flt-1) and VEGFR-2 tyrosine kinases. Both are located in EC. VEGFR-1 can be secreted and 
competitively inhibit VEGF-induced angiogenesis. VEGFR-1 (Flt-1) and VEGFR-2 form a 
new subfamily of receptor tyrosine kinases and both are predominantly expressed in vascular 
endothelial cells during blood vessel formation and remodeling. Knockout mice for VEGFR-1 
(Flt-1) and VEGFR-2 genes demonstrated the critical role of VEGFR-1 in vascular formation 
and VEGFR-2 in sprouting of new capillary blood vessel from preexisting blood vessels. (1) 
1.1.3 Angiogenesis and Cancer 
Cancer researchers studying the conditions necessary for cancer metastasis have discovered 
that one of the critical events required is the growth of a new network of blood vessels. Tumor 
angiogenesis is the proliferation of a network of blood vessels that penetrates into cancerous 
growths, supplying nutrients and oxygen and removing waste products. Tumor angiogenesis 
actually starts with cancerous tumor cells releasing molecules that send signals to surrounding 
normal host tissue. This signaling activates certain genes in the host tissue that, in turn, make 
proteins to encourage growth of new blood vessels. (2) 
Tumor progression and metastasis are classically conditioned where cells escape normal 
growth and adhesion controls and invade, migrate, attach and grow at inappropriate sites. 
Angiogenic factors including growth factors, cytokines, and cell adhesion molecules are 
known to control many of those events. Substantial evidence has been accumulated over the 
years pointing to the dependency of solid tumors on angiogenesis which was first proposed by 
Folkman. (3) 
	
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 As the advancing edge of the tumor approach adjacent microvessels, proangiogenic factors 
are released from the tumor stimulating EC to grow and migrate toward the tumor and 
organize into a capillary network. This switch from the prevascular to vascular phase is 
accompanied by exponential growth of the tumor. An increase in the microvascular density, 
(MVD) in breast and prostate carcinoma has been shown to correlate with malignant and 
metastatic potential and hence with a poor prognosis.  
Tumor cells recruit new blood vessels via various angiogenic factors and are further amplified 
by the release of cytokines, which attract and activate macrophages, mast cells and 
neutrophils. Research involving tumor-associated angiogenesis continues to yield new insights 
into the pathogenic mechanisms of this process. Based on this found understanding, innovative 
and novel therapeutic approaches targeting various steps in this process as well as the 
neovasculature itself may be developed.(1) 
 In addition, as more is learned about the biology of angiogenesis, biological markers may be 
developed that can facilitate of clinical trials. Specific agents currently in clinical trials, as well 
as other approaches under development that act at various points in the complex process 
involved in neovascularization, may soon have an impact on the treatment of neoplastic 
diseases. (3) 
1.2 Computational chemistry   
Chemists have been some of the most active and innovative participants in this rapid 
expansion of computational science. Computational chemistry is simply the application of 
chemical, mathematical and computing skills to the solution of interesting chemical problems. 
It uses computers to generate information such as properties of molecules or simulated 
experimental results. (4) 
Computational chemistry has become a useful way to investigate materials that are too 
difficult to find or too expensive to purchase. It also helps chemists make predictions before 
running the actual experiments so that they can be better prepared for making observations. 
The Schroedinger equation is the basis for most of the computational chemistry scientists’ use. 



This is because the Schroedinger equation models the atoms and molecules with mathematics. 
(5) 
Currently, there are two ways to approach chemistry problems: computational quantum 
chemistry and non-computational quantum chemistry Computational quantum chemistry is 
primarily concerned with the numerical computation of molecular electronic structures by ab 
initio and semi-empirical techniques and non-computational quantum chemistry deals with the 
formulation of analytical expressions for the properties of molecules and their reactions. (4) 
The following three ways are used to perform numerical computation:  
• Ab Initio: The term "Ab Initio" is latin for "from the beginning". This name is given to 
computations which are derived directly from theoretical principles, with no inclusion 
of experimental data, calculating molecular structures using nothing but the 
Schroedinger equation. Most of the time this is referring to an approximate quantum 
mechanical calculation. The approximations made are usually mathematical 
approximations, such as using a simpler functional form for a function or getting an 
approximate solution to a differential equation. (5) 
 
The good side of ab initio methods is that they eventually converge to the exact 
solution, once all of the approximations are made sufficiently small in magnitude. 
However, this convergence is not montonic. Sometimes, the smallest calculation gives 
the best result for a given property. The bad side of ab initio methods is that they are 
expensive. These methods often take enormous amounts of computer cpu, time, 
memory and disk space. In general, ab initio calculations give very good qualitative 
results and can give increasingly accurate quantitative results as the molecules in 
question become smaller. (4) 
• Semi-empirical techniques: use approximations from empirical (experimental) data to 
provide the input into the mathematical models. (5) 

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The good side of semiempirical calculations is that they are much faster than the ab 
initio calculations. The bad side of semiempirical calculations is that the results can be 
erratic. If the molecule being computed is similar to molecules in the data base used to 
parameterize the method, then the results may be very good. If the molecule being 
computed is significantly different from anything in the parameterization set, the 
answers may be very poor.  
Semiempirical calculations have been very successful in the description of organic 
chemistry, where there are only a few elements used extensively and the molecules are 
of moderate size. However, semiempirical methods have been devised specifically for 
the description of inorganic chemistry as well. (4) 
• Molecular mechanics uses classical physics to explain and interpret the behavior of 
atoms and molecules. (5) 
1.3 Quantitative structure activity relationships (QSAR) 
In the process of drug design and development, biological activity evaluation forms the 
premise for compound screening and optimization.(6) Although several experimental methods 
based on receptors and other biological materials of human, rat, mouse and so on, they are too 
costly and time-consuming.(7) 
QSAR is mathematical model relating chemical structures to their biological activity; give 
useful information about drug design and medicinal chemistry (8). In1962 Hansch et. al. 
developed quantitative relationships between biological activity and the octanol water partition 
coefficient .(9) 
Computational methods, especially quantitative structure-activity relationship (QSAR) 
analysis, provides an effective and powerful tool for achieving the same destination with much 
lower cost. Actually, QSAR has now been extensively applied to predict compounds' 
properties, including biological activity, physical property and even toxicity.(10-13)  
QSAR studies aimed to:   

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•  Quantitatively correlate the relationships between chemical structure alterations and 
respective changes in biological endpoint for clarifying which chemical properties are 
most likely determinants for their biological activities. 
 
•  Screening the library for most promising candidates, or optimize the existing leads so as 
to improve their biological activities.  
 
•  Predict the biological activities of untested and sometimes yet unavailable 
compounds.(14) 
 
• QSAR studies can reduce the costly failures of drug candidates in clinical trials by 
filtering the combinatorial libraries. Virtual filtering can eliminate compounds with 
predicted toxic of poor pharmacokinetic properties. It also allows for narrowing the 
library to drug-like or lead-like compounds and eliminating the frequent-hitters, i.e., 
compounds that show unspecific activity in several assays and rarely result in leads. 
Including such considerations at an early stage results in multidimensional 
optimization.  
 
The importance and difficulty of the above-described tasks facing QSAR models has inspired 
many chemoinformatics researchers to borrow from recent developments in various fields, 
including pattern recognition, molecular modeling, machine learning and artificial 
intelligence. This results in large family of conceptually different methods being used for 
creating QSARs. (15) 
  
1.3. 1 General Scheme of a QSAR Study  
To build QSAR model you need to follow four successive steps; preparing the compounds list, 
extracting descriptors from molecular structure, choosing the informative descriptors in the 
context of the analyzed activity, and, finally, using the values of the descriptors as independent 
variables to correlate them with the activity in question. 

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Preparing the compounds list and structure optimization: 
Compiling a list of compounds for which the experimentally determined activity is known. 
Then we must obtain the geometry optimization (minimization) of the compounds by using 
one of two methods: ab initio or semi empirical. The latter one derived from experimental 
values that simplify theoretical calculations, and usually do not require long computation 
times, as in the ab initio (10).  
 
Generation of Molecular Descriptors from Structure 
 
Molecular descriptors must then be computed. Any numerical value that describes the 
molecule could be used. The structure cannot be directly used for creating structure-activity 
relationship for reasons arising from chemistry and computer science. (8). 
First, the chemical structures do not usually contain in an obvious form the information that 
relates to activity. This information has to be extracted from the structure. Various rationally 
designed molecular descriptors clarify different chemical properties implicit in the structure of 
the molecule. Only those properties may correlate more directly with the activity. Such 
properties range from physicochemical and quantum-chemical to geometrical and topological 
features. There is a brief description of those features in table (1.1)  
 
 Second, most methods employed to predict the activity require as input numerical vectors of 
features of uniform length for all molecules. Chemical structures of compounds are diverse in 
size and nature and do not fit into this model directly. To solve this obstacle, molecular 
descriptors convert the structure to the form of well defined sets of numerical values. (15) 
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  Table (1.1) Brief descriptions of the descriptors used in this study: 
Molecular Descriptors Descriptors Type 
Molecular weight (MW),  number of atoms (nAT),  number of 
non H-atoms (nSK), number of bonds (nBT), number of multiple 
bonds (nBM), number of rings (nCIC), number of circuits 
(nCIR), number of H-bond donor (nHDon), number of H-bond 
acceptor (nHAcc). 
 
Constitutional 
Information index molecular size (ISIZ), connectivity indices(X), 
average connectivity index (XA), kier symmetry index (S0K), 
total walk count (TWC), Zagreb index (Z), Schultz molecular 
topological index, Balaban index (J), Wiener index (W) 
 
Topological 
indices 
Highest occupied molecular orbital energy(EHOMO), Lowest 
unoccupied molecular orbital energy (ELUMO), Most positive 
charges(MPC), Least negative charges (LNC), Most negative 
charges(MNC),  Sum of positive charges (SPC), Sum of negative 
charges (SNC),  Sum of squares of positive charges (SSPC),  
Sum of squares of negative charges (SSNC),Sum of squares of 
charges (SSC), Sum of absolute of charges (SAC) ,molecular 
Dipole moment (DM), Electronegativity (=-0.5(EHOMO+ELUMO)). 
Hardness (= 0.5(ELUMO - EHOMO)). Softness (S=1\). 
Electrophilicity (=
2
/2). Heat of formation (Hf). 
Quantum 
Chemical 
Octanol-water partition coefficient (LogP), hydration energy 
(HE) polarizability (Pol), refractivity (Ref), volume (V), surface 
area (SA), 
Chemical 
descriptors 
 
 
Selection of Relevant Molecular Descriptors 
 
Many applications are capable of generating hundreds or thousands of different molecular 
descriptors. Typically, only some of them are significantly correlated with the activity. 
Furthermore, many of the descriptors are intercorrelated. This has negative effects on several 
aspects of QSAR analysis. Some statistical methods require that the number of compounds is 
significantly greater than the number of descriptors. Using large descriptor sets would require 

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large datasets. Other methods, while capable of handling datasets with large descriptors to 
compounds ratios, nonetheless suffer from loss of accuracy, especially for compounds unseen 
during the preparation of the model. Large number of descriptors also affects interpretability 
of the final model. To solve these problems, a wide range of methods for automated narrowing 
of the set of descriptors to the most informative ones is used in QSAR analysis. (15) 
 
Modeling the Descriptors to Activity 
 
Once the relevant molecular descriptors are computed and selected, the final task of creating a 
function between their values and the analyzed activity can be carried out. The value 
quantifying the activity is expressed as a function of the values of the descriptors. The most 
accurate modeling function from some wide family of functions is usually fitted based on the 
information available in the training set, i.e., compounds for which the activity is known. A 
wide range of modeling function families can be used, including linear or non-linear ones, and 
many methods for carrying out the training to obtain the optimal function can be 
employed.(15) 
 
1.4 Statistical methods: 
Among the widely utilized algorithms applied for model construction in QSAR, in our study 
we used multiple linear regression (MLR), partial least squares (PLS), Principle Component 
artificial neural networks (PC-ANN). 
 
1.4. 1 Multiple linear regression (MLR) 
 
The most widely used in QSAR analysis is multiple linear regression analysis, which is a 
powerful means for establishing a correlation between independent variables and dependent 
variable such as biological activity. (10) 
Multiple linear regression models are extremely powerful, and have the power to empirically 
form very complicated relationships between variables. Generally speaking, the technique is 
useful in helping explain observations of a dependent variable, usually denoted y, with 
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observed values of more than one independent variables, usually denoted x1, x2, ... Linear 
regression models have been heavily studied, and are very well-understood.  
The relationship between the dependent variable and independent variables represented by the 
following equation: 
Yi  = 0 + 1xi1 + 2xi2 + ... + pxip + ei                            (1)               
Where: 
 0 is the constant term and 1 to p are the coefficients relating the independent variables to 
the variable of interest. ei: is an error term. 
The term ‘linear’ is used because in multiple linear regression we assume that y is directly 
related to a linear combination of the independent variables. (16) 
The explanatory power of the regression is summarized by its “R-squared” value, computed 
from the sums-of-squares terms as: 
 
R
2
 = SSR/SST = 1- (SSE/SST)                                    (2) 
Where: 



:  Dependent variable found by experiments, : dependent variable found by 
calculation. : average of y.
R
2
, the coefficient of determination, is often described as the proportion of variance described 
by regression. It is important to keep in mind that a high R
2
 does not imply causation. The 
relative sizes of the sums-of-squares terms indicate how “good” the regression is in terms of 
fitting the calibration data. If the regression is perfect, all residuals are zero, SSE is zero, and 
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R
2
 is 1. If the regression is a total failure, the sum-of-squares of residuals equals the total sum-
of-squares, no variance is accounted for by regression, and R
2
 is zero. (17) 
When the factors are few in number, are not significantly collinear, and have a well 
understood relationship to the responses, then multiple linear regression (MLR) can be a good 
way to turn data into information. However, if any of these three conditions breaks down, 
MLR can be inefficient or inappropriate. In such so-called soft science applications, the 
researcher is faced with many variables and ill-understood relationships, and the object is 
merely to construct a good predictive model. (18) 
 
1.4.2 Partial Least Squares (PLS) 
PLS statistical analysis module performs model construction and prediction of activity using 
the Partial Least Squares (PLS) regression technique. It is based on linear transition from a 
large number of original descriptors to a small number of orthogonal factors (latent variables) 
providing the optimal linear model in terms of predictivity. (19)  
In principle, MLR can be used with many factors. However, if the number of factors gets too 
large (for example, greater than the number of observations), you are likely to get a model that 
fits the sampled data perfectly but that will fail to predict new data well. This phenomenon is 
called over-fitting. In such cases, although there are many manifest factors, there may be only 
a few underlying or latent factors that account for most of the variation in the response. The 
general idea of PLS is to try to extract these latent factors, accounting for as much of the 
manifest factor variation as possible while modeling the responses well. (18) 
Unlike some similar approaches (e.g. principal component regression PCR), latent variables 
are chosen in such a way as to provide maximum correlation with dependent variable; thus, 
PLS model contains the smallest necessary number of factors. With increasing number of 
factors, PLS model converges to ordinary multiple linear regression model. In addition, PLS 
approach allows one to detect relationship between activity and descriptors even if key 
descriptors have little contribution to each other.  
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Because latent variables are the linear combinations of original descriptors (with coefficients 
represented by loading vector p), factor model indirectly describes the effect of each descriptor 
on activity. (19) 
Partial least squares regression is an extension of the multiple linear regression models. In its 
simplest form, a linear model specifies the (linear) relationship between a dependent variable 
Y, and a set of independent variables denoted as  X1,X2, … so that 
Y = b0 + b1X1 + b2X2 + ... + bpXp                                    (3) 
Where: 
 b0 is the regression coefficient for the intercept and the bi values are the regression 
coefficients (for variables 1 through p) computed from the data.(16) 
In short, partial least squares regression is probably the least restrictive of the various 
multivariate extensions of the multiple linear regression models. This flexibility allows it to be 
used in situations where the use of traditional multivariate methods is severely limited, such as 
when there are fewer observations than independent variables. Furthermore, partial least 
squares regression can be used as an exploratory analysis tool to select suitable independent 
variables and to identify outliers before classical linear regression. (8) 
 
1.4.3 Principal component-Artificial Neural Networks (PC-ANN) 
 
Artificial Neural Networks (ANNs) are a data processing system consisting of a large number 
of simple, highly interconnected processing elements inspired by the biological system and 
designed to simulate neurological processing ability of human brain. (8)  
Computationally, ANN is an approach for handling multivariate and multi-response data and 
hence suitable for modeling. Unlike standard modeling techniques where the mathematical 
function is required to be known in advance, ANN models do not require knowledge of the 
mathematical function in advance and are called ‘soft models’, i.e. the models are able to 
represent the experimental behavior of the system when the exact description is missing or too 
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complex. ANNs adapt to any relation between input and output data on the basis of their 
supervised training. The characteristics that make ANN systems different from traditional 
computing are: learning by example, distributed associative memory, fault tolerance and 
pattern recognition. The flexibility of ANNs and their ability to maintain their performance 
even in the presence of significant amounts of noise in the input data are highly desirable since 
perfectly linear and noise free data sets are seldom available in practice, thus making it 
suitable for multivariate calibration modeling. (20) 
The basic processing elements of neural networks are called artificial neurons, or simply 
neurons or nodes. In a simplified mathematical model of the neuron, the effects of the 
synapses are represented by connection weights that modulate the effect of the associated 
input signals, and the nonlinear characteristic exhibited by neurons is represented by a transfer 
function. The neuron impulse is then computed as the weighted sum of the input signals, 
transformed by the transfer function. The learning capability of an artificial neuron is achieved 
by adjusting the weights in accordance to the chosen learning algorithm. (8) 
The neurons (hidden units) are non-linear transformation functions. Non linear models can be 
constructed when more than one of these neurons is used. ANN can model a wide set of 
functions, as in figure (1.1). The input is multiplied by the connection weight, while products 
are summed at each neuron where a nonlinear transfer function is applied. The output of each 
neuron is then multiplied by the connection weight and summed and interpreted until having 
the minimum error (20).  
  
 
 
 
 
 
 
 
 
 
Figure (1.1): Schematic Diagram of a Neural Network. 

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For better predictive model we used Principle Component Analysis (PCA) which is a useful 
tool for reducing the number of variables in a data set and for obtaining useful two 
dimensional views of a multi-dimensional data set. Thus, irrelevant and unstable information 
is discarded from the regression analysis.  
Principal component analysis (PCA) groups together variables that are collinear to form a 
composite indicator capable of capturing as much of common information of those indicators 
as possible. Each factor reveals the set of variables having the highest association with it. The 
idea under this approach is to account for the highest possible variation in the indicators set 
using the smallest possible number of factors. Therefore, the index no longer depends upon the 
dimensionality of the dataset but it is rather based on the “statistical” dimensions of the data. 
Application of PCA on a descriptor data matrix results in a loading matrix containing factors 
or principal components, which are orthogonal and therefore do not correlate with each other. 
We used these factors as the inputs of ANN instead of the original descriptors.  
 
Principal component-artificial neural network (PC-ANN) joins PCA with artificial neural 
networks (ANN), the flexibility of ANN for finding out relationships that are more complex 
allows this method to be widely applied in QSAR studies. (21) 
 
1.5 Software in QSAR 
    A huge number of computer programs to serve QSAR produced in the last 50 years, these 
programs help in the progression of QSAR and make it easy to achieve all QSAR goals. 
We used in our study the following four softwares:  
HyperChem (version 8.0 HyperCub, Inc.), Dragon (version 3, Milano Chemometrics and 
QSAR research group, http://www.disat.unimib.it/chm/Dragon.htm), SPSS (version 11.50, 
SPSS Inc.), Matlab (version 7.0, Math works Inc, http://www.mathworks.com)  
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1.5.1 Hyperchem 
 Hyperchem software is a sophisticated molecular modeling environment that is flexible, easy 
to use, and high quality program. Hyperchem integrates 3D visualization and animation with 
quantum chemical calculations, molecular mechanics, and dynamics. 
Hyperchem can be used to: building molecular structures, structure optimization, calculating 
some QSAR descriptors, computing some structural properties, studying dynamic behavior, 
etc. 
In this research we used the hyperchem software to build the structure, optimizing the 
structure, and to calculate some structural properties and molecular descriptors. Before 
calculation of any property of the molecule, the structure must be optimized (minimized). 
The tool menu is shown in figure (1.2) where we can use any tool to draw, display, optimize, 
calculate, and then we can use the model builder to transform (2D) structures to (3D) 
structures. 
 
Figure (1.2): Hyperchem main menu. 
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1.5.2 Dragon software 
Dragon software is designed for the calculation of theoretical molecular descriptors, it is  
developed by Milano chemometrics  and QSAR research group to calculate molecular 
descriptors for molecules containing the following atoms: C, H, O, N, S, P, F, Cl, Br, I, B, Si, 
Ni, Fe, Co, Al, Cu, Zn, Sn, Gd. 
The number of different descriptors that can be calculated by Dragon software is 1481 
descriptor, and this huge number of descriptors is divided into 18 groups such as: topological 
and geometrical descriptors …etc.  
The Descriptors calculated by Dragon represent an input to the QSAR analysis programs, 
these descriptors are the independent variables in the models that we aim to build. 
1.5.3 SPSS software 
SPSS (Statistical Package for the Social Sciences) was released in 1968 after being developed 
by Norman H. Nie and C. Hadlai Hull. SPSS is the most widely used program for statistical 
analysis, it uses two main windows: data editor and output viewer.  
 1.5.3.1 Data Editor 
This is a spreadsheet-like window which contains the data to be analyzed. The data editor has 
two views:  
Data View which contains the data and it is the view we see when we open the data editor, 
figure (1.3).  When we click the tab at the bottom of the window brings up the Variable View 
which does not contain data, but displays information about the dataset that is stored, figure 
(1.4). We can control how SPSS displays data from this window. Each data editor contains 
one dataset. Multiple data editors can be opened at one time, in which each one contains a 
separate dataset. Datasets that are currently open are called working datasets. All data 
manipulations, statistical functions, and other SPSS procedures operate on these datasets. 
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Figure (1.3): Data view window 
 
 
Figure (1.4): Variable view window  
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1.5.3.2 Output Viewer     
This is where the results of any analysis appear. From the viewer, we can format the output in 
a wide range of ways, and export results in a variety of formats, e.g. text, SPSS, MSWord, MS 
Excel, etc. 
In this study we will use SPSS software to perform MLR analysis. 
1.5.4 MATLAB software 
A high-level language and interactive environment program that enables us to perform 
computationally intensive tasks faster than with traditional programming languages such as C, 
C++, and Fortran. Wide range of applications can be performed by matlab, including image 
processing, test and measurements, control design, and computational biology. 
MATLAB provides a range of numerical computation methods for analyzing data, developing 
algorithms, and creating models. The MATLAB language includes mathematical functions 
that support common engineering and science operations. Core math functions use processor-
optimized libraries to provide fast execution of vector and matrix calculations. 
Available methods include: 
• Interpolation and regression 
• Differentiation and integration 
• Linear systems of equations 
• Fourier analysis  
• Eigenvalues and singular values 
• Ordinary differential equations (ODEs) 
• Sparse matrices  
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MATLAB add-on products provide functions in specialized areas such as statistics, 
optimization, signal analysis, and machine learning. 
The use of matlab depends upon the script used and the input files. We used matlab in our 
study to do MLR cross validation by applying (leave one out (LOO) and leave many out 
(LMO) methods), to perform principal component analysis in order to divide the data before 
starting ANN, to perform the PC- ANN model and to perform PLS model. 
1.6 Objective: 
 The main objective of this study is to develop QSAR models for the inhibition activity of 192 
chemical compounds of vascular endothelial growth factor receptor-2 (VEGFR-2) by applying 
different statistical qualities such as MLR, PLS and PC-ANN. These models will be used to 
design new inhibitors.     
 
 


 
 
 
Chapter two 
Methodology 
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In this study we aimed to build QSAR model that can be used to calculate the activity of a 
chemical compound as anti VEGFR-2, using several statistical methods performed by several 
softwares (mentioned before). This is achieved by the steps shown in this chapter. 
To build QSAR model you need to follow four successive steps as mentioned bellow:  
 preparing the compounds list 
 extracting descriptors from molecular structure 
 choosing the informative descriptors  
 modeling the Descriptors to Activity 
2.1 Data preparation  
2.1.1 Compiling the compounds list 
A data set of 192 vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase 
inhibitors and their activity (pIC50) were obtained from the literature (22 -31) and used in this 
study. The chemical structure and the biological activity of these compounds are summarized 
in table (2.1) 
We aimed to select the compounds from a group of studies so we end up with a list of 
compounds with variety of cores. This list was used to have a comprehensive model that can 
be applied on many compounds with different cores. 
The activity in the list is expressed as pIC50 (- log (The half maximal inhibitory concentration)) 
which is indicator of how active the compound is. 
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Table (2.1): The chemical structure and the biological activity of the compounds used in this 
study. 
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2.1.2 Structure drawing and optimization: 
The Chemical structures of the whole 192 compounds were taken from the references (22-31). 
And then they were drawn using hyperchem software.  
To perform geometry optimization for the chemical structure you have to follow the steps 
below: 
1. First draw the structure using drawing tools. After drawing we choose “add H &model 
building” from build menu to have the 3D structure. 
2. Then Click on “start log” in the file menu to give it a name, and choose a directory to 
save it. 
3. From the setup menu choose “semi-empirical” method of calculation and then select 
“AM1” from the semi-empirical window as shown in figure (2.1). 
 
Figure (2.1): semi-empirical method window. 
4. Click on the options button of the semi-empirical window and select geometry 
optimization parameters, choose total charge= 0, spin multiplicity= 1, spin pairing = 
RHF, convergence limit=0.1, and accelerate convergence= yes as shown in figure (2.2). 



 
  Figure (2.2): Semi-empirical options window. 
5. Click OK to close the semi-empirical options dialog box, and then click OK to close the 
semi-empirical method dialog box.   
6. Choose “geometry optimization” from compute menu, this opens semi-empirical 
optimization dialog box as shown in figure (2.3). 
 
Figure (2.3): Semi-empirical optimization window 
7. Select Polak-Ribiere as algorithm method, choose 0.01 for RMS gradient condition, and the 
default values for the other variables, then click OK to initiate the optimization and close the 
dialog box. The software will choose the maximum cycles, but we can increase, if needed.  
8. Finally,  when the program finish  the optimization, select “stop log” from the file menu to 
save the calculation output as log file. And then save the structure as HIN file. 


By finishing these steps we had 192 HIN files that represent the optimized chemical structures 
of the compounds, which is the input of Dragon software. And 192 log files that represent the 
calculations output.      
2.2 Extracting descriptors from molecular structure 
The chemical structure can’t be linked directly with the activity, so theoretical descriptors are 
the way of how the activity is linked with the chemical structure of the compounds. Nineteen 
groups of descriptors were calculated directly and indirectly using Hyperchem Dragon 
softwares.  
2.2.1 Descriptors calculated by Hyperchem  
First, from the output file of hypechem Calculation,   we can get some descriptors. 
We got highest occupied molecular orbital energy (EHOMO), lowest unoccupied molecular 
orbital energy (ELUMO), molecular Dipole moment (DM), and Heat of formation. 
Second, using hyperchem we can calculate some other descriptors. 
We computed Surface Area (Approx), Surface Area (Grid), Volume, Mass, Hydration Energy, 
Octanol- water partition coefficient (Log P), Refractivity, Polarizability. 
We calculated them according to the steps below: 
1. Open the Hyperchem file of the chemical structure of the compound (HIN file) 
2. Open compute menu, select “QSAR properties” , this will open widow as in figure 
(2.4) 


 
Figure (2.4): QSAR properties window. 
3. From options menu, select output to “result window”. 
4. Then click on the property, then compute button for each property. 
5. Finally save the result window as “log file”  
2.2.2 Descriptors calculated manually  
A group of four quantum descriptors was calculated manually by using excel software 
according to theequations below:    
Electronegativity =">(?	 %*,#,@%<A#,"
 Hardness B">?	 %<A#,(%*,#,"
Softness  >CB"?
Electrophilicity  D">=EB
We gathered the whole quantum descriptors in one excel file ready to be used in the further 
steps.  
2.2.3 Descriptors calculated by Dragon software: 
By Hyperchem we calculated one group of descriptors which is quantum descriptors. The 
other eighteen groups (shown in figure 2.5) was calculated using Dragon software.                                    
To calculate the descriptors using dragon: 


1. Prepare folder that has the chemical structure (HIN files from hyperchem) of all the 
compounds you want to use in the study (192 in our case). 
2. Open dragon software, the program will open a window as in figure (2.5).  
 
   
             Figure (2.5): Dragon software window.  
3. Click on calculate descriptors. 
4. Then open the compounds folder, open the files type (HIN files), and select all the 
compounds to inter the calculation.  
5. Click on descriptor selection button   
6. Now open the descriptors group/ groups “we calculated each descriptors groups for all 
the compounds alone”.  
7. Select the calculation terms; click on “stop calculation in error”  
8. Press Run button to start calculation. 
	
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9.  Finally, after the software calculation finished name and save the output.   
At the end of this work, we had separate file for each group of descriptors ready to be used 
in the next step. 
2.3 Choosing the informative descriptors: 
The descriptors which calculated by dragon and hyperchem software were 1497 descriptors. In 
this step, the subgroup of the descriptors that can provide the best model that can predict the 
activity is chosen.   
SPSS software was used to perform this step. By using each group of descriptors (dragon and 
Hyperchem descriptors) to built one MLR model. And then collect the descriptors chosen by 
each model of the MLR models in one excel file (final MLR file). And perform MLR another 
time for the final file to choose the best subgroup of the descriptors.    
To perform MLR analysis using SPSS software you need to follow the following steps: 
1. Prepare the files to be used as SPSS input; excel files that has the experimental activity 
(dependent variable) as the first column, and the descriptors (the independent 
variables) as the rest of the columns. 
2.  Open the file containing the dependent variable and independent variables using 
SPSS, then go to analyze menu and choose regression and select linear as in figure 
(2.6). 
	


Figure (2.6): SPSS Data Editor Menu
3. Set activity as the dependent variable and set the descriptors in the input file as the 
independent variables in the linear regression dialog box, and then press on the options button 
of the same dialog box as shown in figure (2.7). 
 
Figure (2.7): Linear regression box.  
	

4. Select use F value and set F Entry and F Removal values and leave other parameters 
without any change in the linear regression option dialog box. 
5. Choose the method to be stepwise, click save to store results back to the input sheet, choose 
the predicted values to be unstandarized and then click continue. 
6.Click statistics to generate additional statistics for variables then click continue, and finally 
click OK in the linear regression dialog box. 
By finishing these steps, we will have linear model for each group of descriptors, which 
contain the best informative descriptors from each group. So these steps must be performed 
again on a file that has the whole descriptors chosen by the MLR models of each group of 
descriptors (final MLR) to result with final model that has the best informative descriptors 
from the whole 1497 descriptors. 
We aimed in this part of the work to extract the informative descriptors, at the same time we 
built the linear model that link the activity with the descriptors.  
 
2.4 Modeling the Descriptors to Activity 
2.4.1 MLR validation: 
At the end of the previous step, part of the statistical analysis work will be finished.  The work 
end with several final MLR best models that relate the activity with the descriptors linearly, so 
those models need to be validated.   
Cross validation is a technique taken to evaluate the ability of the QSAR model to predict the 
activity of chemical compound that not used in building it. (32) 
R
2
 (coefficient of determination) which is a statistical parameter that can indicate the goodness 
of the model. R
2 
is a measurement of
 
how the regression line perfectly fits the real data points. 
If the regression is perfect R
2
 is 1, but if the regression is a total failure then R
2
 is zero. 
R
2
 does not indicate the quality of the model, so focusing on maximizing the value of R
2
 alone 
is not a good idea. We need other parameters to evaluate the ability of the model.   
R
2 
is calculated by SPSS program
 
while building the model. 
 
 
	
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2.4.1.1Cross validation by using MATLAB 
Leave One Out Cross Validation 
Leave-one-out cross validation done by using a single observation from the original data set  
as the validation data, and the remaining observations as the training data. This is repeated as 
the number of data set, such that each observation in the sample is used once as the validation 
data. This type of cross-validation is usually expensive from a computational point of view 
because of the large number of times the training process is repeated (33). 
This type of validation is performed by the following steps: 
 
1- Prepare the input file by copying the observed and predicted activity columns from the 
SPSS data editor and paste them in an excel file and save it. The observed activity should be 
the first column and then comes the predicted activities. 
2-   Copy excel file to Matlab working directory   (C:\MATLAB701\work) or any directory 
you are working in. In the same directory, there should be a file (script) with the name 
(cross_val_param_loop.m) which will perform the validation. 
3- Open the script file, then you will have a message on Matlab window says “what is the file 
name”, enter the excel file name with or without the (.xls) extension. Then you will have a 
message says “model number”, where the next line contains number that is the model number.  
4-  Matlab script will ask you for the number of descriptors for each individual model. 
Towards the end, cross validation results for all models will be saved in a file called 
“CV_LOO.dat” on the directory (C:\MATLAB701\work) or the directory you are working in. 
Leave Many Out Cross Validation 
In leave many out cross-validation, the original sample is randomly partitioned into X 
subsamples. Of the X subsamples, a single subsample is considered as the validation data for 
testing the model, and the remaining (X – 1) subsamples are used as training data. The cross-
validation process is then repeated X times, using each of the X subsamples once as the 
validation data (33). 
This type of cross validation is done by the following steps: 
	
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1- Prepare an excel file that contains the activity (first column) and the descriptors entered in 
the regression model of interest.   
2-  Then run Matlab script “lgocv.m”. This script performs leave-group-out cross validation 
where 20% of the data are classified as test set so that each compound is entered only once in 
the test set.  
3-  Enter excel filename and number of compounds to be used in the training set when you 
are asked for these information and press enter. 
4- The output file: “CV_LGO.dat”, appears in the same directory in addition to printing cross 
validation parameters on the screen.  
2.4.2 Principal component-Artificial Neural Networks (PC-ANN) 
We consider the relation between the activity and the chemical descriptors more complicated 
than a linear relationship so we perform PC-ANN analysis, hoping to end up with better 
models than MLR models.    
After using SPSS software to perform MLR analysis, we finished up with several good MLR 
models; those models will be the input to PC- ANN step. The choice of the best models 
depends on their validation parameters. 
After choosing which MLR models are the best, you need to perform the following steps: 
First you must perform Principal component analysis (PCA): 
Before starting ANN analysis, you should divide the data into training, validation and external 
test set. We use PCA to perform this step, because the division should not be done randomly.  
Data division should be done as to have 60% of the data in the training set and 20% for each 
of the validation and test sets.  
1-   Prepare an excel file containing the experimental activity as the first column, and the 
descriptors of the whole chosen models as the rest of the columns. 
2- Use Matlab script “calcpcaplot.m” to perform the analysis (the script file and the file you 
work on should be in the same directory).Open the script file, by going to Matlab menu and 
click on the open file icon, and then run the script. 
		
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3- After running the script you will be asked about the file name, Enter the name of the file 
that you prepared. 
4- Then you will obtain a figure with a scatter distribution of the data (compounds), each 
compound indicated by a point when you press it, the compound number appears. Select the 
training, validation and test sets molecules from these data points so they span the same space 
of the entire data.    
 
Second performing ANN model: 
1- Prepare an excel file for each model of the chosen MLR models. Each file should contain 
the experimental activity as the first column and the descriptors used in the model as the other 
columns.  
2- To implement the data division on ANN analysis, you should edit the matlab script 
“ann_ext_test_4loop.m” to indicate the training, validation, and test sets in the calculation.  
3- Then, you must open and run the matlab script “nnloop.m” which read the previous script 
and perform the analysis to end up with the model. 
You may also need  to modify  the R (regression coefficient) value in the  script “nnloop.m”  
to make it stop, because it will still working until it reach the value in the script (we chose it to 
be more than 0.75 , 0.8 according to test set and training set respectively). When you run the 
“nnloop.m” script, you will be asked for the excel file name for the model of interest, model 
number (to be inserted) and number of hidden nodes. To run the “ann_ext_test_4loop.m” file, 
a Matlab script named “subplotspace.m” should be in the same directory.
When the work is done, the cross validation results will be printed out on Matlab screen at the 
end of optimization and saved in a file with the name “CV_model_”N”_hn”H”.dat“, where 
“N” is the model number and “H” is the number of hidden nodes. 
The steps are done for each one of the chosen models and cross validation results for each 
model will be compared with each other in order to choose the best one?
The script “ann_ext_test_4loop.m” produces three regression figures, one for each data set. 
These files are named as “'mlr_”test”_model_”N”_hn”H”.fig”, where N and H are the same as 
in the cross validation file and “test” is replaced with “train” and “validation” for the training 
and validation sets, respectively.  
	

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The residue, the difference between predicted and observed activities for each data is saved to 
a file named as “pred_obs_”test”_model_”N”_hn”H”.dat” while for  the complete data 
without division, the file is named “ “pred_obs_all_model_”N”_hn”H”.dat”. Residue figures 
for each data set are     named “residue_”test”_model_”N”_hnee”H”.fig” 
4- After choosing the optimal models, you have to optimize the number of hidden nodes for 
these models. To do so, you have to choose a range for hidden nodes numbers (in our case 3-
20) and optimize the network for each number of hidden nodes. The optimal model choice is 
based on cross-validation results.  
After these steps you will end up with several PC_ANN models, you choose the best of them 
according to the cross validation parameters. 
 
Third: Randomization  
Chance correlation  
For further validation, run chance correlation test for the optimal models. In this test, the 
activity column is being randomized and the network performance is checked. To perform this 
test, run Matlab script “nn_chance_corr_new.m”. When you are asked for; enter the excel file 
name for the model of interest, model number, number of hidden nodes and trial number for 
chance correlation test. The output is similar to that original model.  
Then the cross validation parameters values of the original models compared with the ones of 
the chance correlation models. They shouldn’t be the same to prove that our work doesn’t 
produced by chance. 
 
Y- randomization: 
And to ensure the robustness of the optimal models we applied Y- randomization. The Y-
randomisation technique proceeds with scrambling of the Y-column data, keeping the 
descriptor matrix unchanged. The models were built using the scrambled data (by the same 
steps as with ANN) and the values of correlation coefficients were calculated. If the 
correlation coefficients are lower than the results of the original models. This indicates that the 
developed models considered being robust enough. And the value of cR
2
p is calculated. These 
	

values should be above 0.5 to consider the model acceptable and it is calculated by the 
equation below. (34) 
 
 
Where: 
R:correlation coefficient. 
R
2
: coefficient of determination. 
r: for randomization.  
2.4.3 Partial Least Squares (PLS) 
In this part of the work we aimed to build a linear relation between the activity and the 
descriptors using another linear method other than MLR. 
In this method the descriptors which have correlation will be gathered in one latent variable 
which indicates them and that’s to avoid the intercorrelation that may be happen in MLR. PLS 
is performed using Matlab software. 
PLS is done by the following steps: 
 
1.In the previous work (PC-ANN) the data set (188 compounds) was divided into three sets, 
training, validation and test sets. In this part of work we need training and test sets only, so we 
combine the training and the validation sets together to form the new training set (80% of the 
data set) for the PLS work. While test set used as test set (20% of the data set) for the PLS 
work.   
2.After dividing the data set, prepare four notepad files for each model of the chosen MLR 
models, as following: 
Xcal: that has the columns of descriptors (independent variables) of training (cal) set. 
Ycal: that has the column of activity (dependent variable) of training set. 
Xtest: that has the columns of descriptors (independent variables) of test set. 
Ytest: that has the column of activity (dependent variable) of test set. 
3.Open the Matlab software in the pathway in which the script needed is present, which is 
“PLS.M”. 
4.Type the following commands in the Matlab sheet:  
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>> load xcal.txt 
>> load ycal.txt 
>> load ytest.txt 
>> load xtest.txt 
This commands to load the files that have our data. 
Then type the following commands in Matlab sheet then click inter. 
 
>> [p, q, w, b, t, u, x, y, l] = pls(xcal', ycal', 10); 
>> plsprs = plspress(xcal', ycal', p, q, w, b, 10); 
 
Then type the command : >> plot(plsprs,’*’) then click inter. 
Those commands typed to run the needed script.  
5.At this time a plot is appeared. You should choose the point in which the curve remains 
constant after it, which define the number of Latent variable. 
6.Type  
>> [c, x] = plspred(xtest', p, q, w, b, 2); 
Before clicking enter, You should change the number 2 in the command with the point 
obtained from the step 5 and then click enter in the Matlab program.  
Choosing this point is dependent on the respective curve and can vary in diverse datasets. 
This command is used to bring out the predicted activity values of the test set. 
7.Type the command : >> predtest=c';  then click enter 
From the workspace menu you can find the predicted results in the predtest. 
8.Type  
>> [c, x] = plspred(xcal', p, q, w, b, 2); 
Before clicking enter, You should change the number 2 in the command with the point 
obtained from the step 5 and then click enter in the Matlab program.  
Choosing this point is dependent on the respective curve and can vary in diverse datasets. 
This command is used to bring out the predicted activity values of the training set. 
9.Type the command : >> predcal=c';  then click enter 
From the workspace menu you can find the predicted results in the training set. 
 
10. The cross validation of this part is done using Leave one out way as clarified before. 
	

 
 
 
 
Chapter Three 
Results and Discussion 
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To improve the studies that concern about tumor growth, we developed MLR- QSAR model 
that relates the activity of 192 anti vascular endothelial growth factor receptor-2 (VEGFR-2) 
to their structures using their theoretical descriptors as structure indicators. It is evident that 
direct inhibition of the kinase activity of VEGFR-2 will result in the reduction of angiogenesis 
and the suppression of tumor growth. The work was done by following successive steps using 
several softwares to build the linear and non linear models and perform their validations.  
The methodology was explained in the previous chapter and the results are discussed in this 
chapter. 
Descriptors calculation 
We take the structures and experimental activity values of our 192 compounds from the 
literature (22-31). The compounds were gathered together to deal with them as one set. The 
compounds structures and their activities as pIC50 are summarized in table (2.1). Hyperchem 
software was used to build the structure of each one of the compounds and AM1 semi-
empirical method was used to optimize the chemical structures. Then the same software was 
used to calculate quantum chemical descriptors group directly and indirectly and they all 
gathered in one excel file, and this is the first group of 19 descriptors groups. 
Dragon software was used to calculate the other eighteen groups of descriptors. We discarded 
the constant or near constant descriptors because they cannot differentiate between the 
different compounds. Dragon discarded the whole descriptors of three groups which are 
empirical, properties and aromaticity indices descriptors because the previous reason. Our 
output were fifteen files each one has the results of one group of the descriptors which are  
constitutional, topological, molecular walk counts, BUCT, galvez topological & charge 
indices, charge descriptors, 2D autocorrelations, randic molecular profiles, geometrical, RDF, 
3D-MoRSE, WHIM, getaway, functional groups and atom-centred fragments descriptors.  
At the end we had sixteen groups of descriptors; we gathered the small groups of descriptors 
together. We gathered five groups of descriptors; charge descriptors, galvez topological & 
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charge indices, molecular walk counts, randic molecular profiles and quantum descriptors in 
one excel file to end up with twelve groups. 
This part of work end up with twelve excel files, ready to be used in the next step. 
MLR  
The twelve files of calculated theoretical descriptors were used to perform MLR analysis 
using SPSS software by stepwise regression method. MLR analysis were performed on the 
twelve descriptors groups individually rather than dealing with them as one group according to 
the work done by Deeb (35). This method constructs the model in stages.  It starts by trying 
out one independent variable at a time and including it in the regression model if it is 
statistically significant, and eliminating those that are not statistically significant. 
The results of performing MLR regression on the twelve groups of descriptors  are 
summarized in table (3.1), with each group we tried to reach a model with the highest 
correlation coefficient (R) and in the same time the lowest number of descriptors. That is 
because we wanted to have only the descriptors that have a direct relation with the activity and 
we wanted to reduce the inter correlation between descriptors in the model as much as we can.      
Table (3.1): The descriptors and correlation coefficient values of MLR models for each group 
of descriptors.  
No 
	
 Group name R
	
 R
2
 
	
 R
2
 
adj.
	
 
Selected descriptors.
	
 
1 2D descriptors 0.86 0.74 0.70 MATS1e,MATS7e,GATS8p,ATS8e, 
GATS8v,MATS1v,MATS1p,MATS6m, 
ATS6v,GATS6m,MATS7p,ATS2v, 
GATS1m,ATS3p,GATS6v,GATS5v,              
ATS2m,MATS4v,ATS7v,ATS6e,             
MATS4e,GATS4e,ATS4m,MATS6p,      
ATS6p,ATS2e,MATS7v,MATS4m 
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2 3D morse 0.83 0.70 0.65 Mor27u,Mor05u,Mor05m,Mor20v, 
Mor04v,Mor10u,Mor31v,Mor31m,           
Mor02u,Mor03m,Mor06v,Mor08u,           
More28u,Mor21m,Mor25v,Mor29u,         
Mor29m,Mor23u,Mor25u,Mor19v,           
Mor15u,Mor25m,Mor31u,Mor17u,           
Mor04u 
3 Atom-centred 0.83 0.68 0.65 C-030, N-069, C-041, C-016, C-025,   C-006, 
C-013, F-084, O-059, C-032,    C-005, N-068, 
N-075, C-026, C-028,       H-050, O-060, O-
057, H-049 
4 BUCT desc. 0.77 0.60 0.52 BELp8, BELm3, BEHp7, BEHv2,           
BEHe2, BELm6, BELe3, BELe1,    BELm2, 
BELe8, BELm7, BELe7,         BELm4, 
BEHm8, BELm1, BELv6,       BELm8, 
BELm5, BEHv5, BEHm5,          BEHm4, 
BEHp3, BEHe3, BEHm2,           BEHm6, 
BEHv6, BEHm3, BEHm1,        BELe2, 
BELp4, BEHe7, BEHm7  
5 Constitutional  0.79 0.62 0.57 nS, nCIR, RBF, nF, nR07, Me, nBM, Mp, nO, 
nR09, nCIC, nH, nBnz, Mv, Ms, Ss, Sp, nR05, 
nTB, AMW  
6 Function desc. 0.81 0.65 0.62 nCOOH, nCOPh, nHAcc, nNHRPh, nNH2, 
nNHR, nROR, nCN, nCONN, nCO, 
nCONHR, nSO2, nRCX3, nCq, nCrH2, nCaH, 
nCs, nCp 
7 Geometrical  0.75 0.55 0.48 G1, G(O..O), G(N..O), G(N..S), G(O..Cl), 
SPH, MAXDP, G(S..F), L/Bw, RGyr, FDI, 
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ADDD, SPAM, PJI3, G(N..F), SPAN, 
G(O..Br), MAXDN, G(S..S), J3D, W3D, 
MEcc, G(N..N), TIE, G(N..Br), ASP 
8 Getaway  0.80 0.64 0.61 R6v+, HATS1u, R4e+, H6m, R1p+, R3p+, 
HGM, R5m, HATS5v, HATS6m, H6u, R8v, 
R2p, R8v+, R8p+, R1v+ 
9 RDF desc. 0.78 0.60 6 RDF025m, RDF010m, RDF050v, RDF075m, 
RDF050u, RDF140v, RDF145u, RDF030m, 
RDF050m, RDF020p, RDF080u, RDF040m, 
RDF090m, RDF070v, RDF080v, RDF110m, 
RDF135m, RDF020u, RDF075v, 
10 Topological  0.83 0.68 0.65 AAC, SEigZ, IC1, T(O..Cl), Xt, PJI2, D/Dr10, 
Jhetv, SPI, T(O..F), X4Av, Yindex, ZM2V, 
VEA1, ww, BIC4, T(N..N), IVDM 
11 Whim desc. 0.72 0.52 0.43 G2s, Dm, E1u, Ds, G1s, G2m, E1m, G2u, As, 
L2p, Ap, G1e, Du, G2e, G1p, G1u, G2p, G1m, 
E3v, E3u, E2m,  P1p, E2v, P2s, E2s, L3s, Ts, 
L2s, Tv, E3s, L3v, 
12 Chargeextra
		
 0.80 0.64 0.60 RPCG, JGI2, GGI4, qneg,GGI2, Hydration, 
Refractivity, Qneg, DP01, GGI5, PCWTe, 
GGI10, SHP2, dipole, RNCG, SRW05, SP04, 
LUMO, JGI10, GGI8, Heat of formation, 
JGI5, GGI6  
* No. refers to group number, R refers to correlation coefficient, R2 refers to coefficient of determination, R2adj:  
refers to adjusted R2, Selected descriptors refer to descriptors chosen by the last MLR model. 
**Charge extra refers to: galvez topological & charge indices, molecular walk counts, randic molecular profiles 
and quantum chemical descriptors. 
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After having those MLR models with the best descriptors in each group we gathered those 
descriptors (as the independent variables) in one SPSS data file with the activity (p IC50) as the 
dependent variable. And then final MLR model was performed using this file. The results of 
this step are summarized in the table (3.2). The table shows the models that had R
2
 over than 
0.6 because with lower R
2
 the model not accepted. (35) 
Table (3.2): The best models of the final MLR: "models have R
2
 over than 0.6"  
Model 
No. 
No. of 
descriptors 
R R
2
 R
2
 adj. Selected desc. 
6 6 0.78 0.61 0.60 BELp8, nNHRPh,ATS4m,nCOOH, C-032, 
Mor27u 
7 7 0.79 0.63 0.62 BELp8, nNHRPh,ATS4m,nCOOH, C-032, 
Mor27u, C-005 
8 8 0.80 0.64 0.63 BELp8, nNHRPh,ATS4m,nCOOH, C-032, 
Mor27u, C-005, MATS7e 
9 7 0.80 0.64 0.63 BELp8, nNHRPh,ATS4m, C-032, Mor27u, C-
005, MATS7e 
10 8 0.81 0.65 0.64 BELp8, nNHRPh,ATS4m, C-032, Mor27u, C-
005, MATS7e, BELe3 
11 9 0.82 0.67 0.65 BELp8, nNHRPh,ATS4m, C-032, Mor27u, C-
005, MATS7e, BELe3, Mor02u 
12 10 0.82 0.68 0.66 BELp8, nNHRPh,ATS4m, C-032, Mor27u, C-
005, MATS7e, BELe3, Mor02u, G2u 
13 11 0.83 0.69 0.67 BELp8, nNHRPh,ATS4m, C-032, Mor27u, C-
005, MATS7e, BELe3, Mor02u, G2u,PJI2 
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14 12 0.84 0.70 0.68 BELp8, nNHRPh,ATS4m, C-032, Mor27u, C-
005, MATS7e, BELe3, Mor02u, G2u,PJI2, G2s 
15 13 0.85 0.72 0.69 BELp8, nNHRPh,ATS4m, C-032, Mor27u, C-
005, MATS7e, BELe3, Mor02u, G2u,PJI2, 
G2s, nROR 
16 14 0.85 0.72 0.70 BELp8, nNHRPh,ATS4m, C-032, Mor27u, C-
005, MATS7e, BELe3, Mor02u, G2u,PJI2, 
G2s, nROR, BELp4 
17 15 0.86 0.73 0.71 BELp8, nNHRPh,ATS4m, C-032, Mor27u, C-
005, MATS7e, BELe3, Mor02u, G2u,PJI2, 
G2s, nROR, BELp4, RDF090m 
18 14 0.86 0.73 0.71 nNHRPh,ATS4m, C-032, Mor27u, C-005, 
MATS7e, BELe3, Mor02u, G2u,PJI2, G2s, 
nROR, BELp4, RDF090m 
19 15 0.86 0.74 0.72 nNHRPh,ATS4m, C-032, Mor27u, C-005, 
MATS7e, BELe3, Mor02u, G2u,PJI2, G2s, 
nROR, BELp4, RDF090m, Mor08u 
20 14 0.86 0.74 0.72 nNHRPh, C-032, Mor27u, C-005, MATS7e, 
BELe3, Mor02u, G2u, PJI2, G2s, nROR, 
BELp4, RDF090m, Mor08u 
21 15 0.87 0.75 0.73 nNHRPh, C-032, Mor27u, C-005, MATS7e, 
BELe3, Mor02u, G2u,PJI2, G2s, nROR, 
BELp4, RDF090m, Mor08u,GGI4 
22 16 0.87 0.76 0.74 nNHRPh, C-032, Mor27u, C-005, MATS7e, 
BELe3, Mor02u, G2u,PJI2, G2s, nROR, 
BELp4, RDF090m, Mor08u,GGI4, nCONHR 
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As it’s obvious in table (3.2) the best model with highest R
2
, R
2
adj is model 22. Model 22 
represented by the following equation:   
pIC50 = 9.478 (±2.848) + 2.272 (± 0.284) nNHRPh – 1.053 (± 0.249) C-032 - 0.964 (±0.155) 
Mor27u – 0.140 (± 0.069) C-005 + 0.908 (± 0.315) MATS7e – 3.236 (± 0.644) BELe3 + 
0.015 (± 0.007) Mor02u + 21.013 (± 5.348) G2u – 2.186 (± 0.551) PJI2 – 21.897 (± 9.297) 
G2s – 0.333 (± 0.082) nROR + 2.328 (± 0.621) BELp4 +0.046 (± 0.014) RDF 090m – 0.233 
(± 0.060) Mor08u + 0.278 (± 0.104) GGI4 – 0.219 (± 0.095) nCONHR. 
 
According to the above equation, the most important descriptors are G2s and G2u which 
reflect the molecular geometrical coordinates of the compounds; G2s is inversely proportional 
to the inhibitory activity of the compounds while G2u is directly proportional to the inhibitory 
activity of the compounds.  
R
2
 is statistical parameters that give some information about the goodness of fit of a model. In 
regression, the R
2
 coefficient of determination is a statistical measure of how well the 
regression line approximates the real data points. An R
2
 of 1.0 indicates that the regression 
line perfectly fits the data, while R
2
 of zero indicates no 'linear' relationship between the 
dependent variable and independent variables. R
2
 is only a descriptive measure and it does not 
measure the quality of the regression model. Accordingly, focusing solely on maximizing R
2
 
is not a good idea. So we need extra validation for MLR models to judge the productivity of 
the models. 
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We applied LOO and LMO cross validation on the MLR models in table (3.2) using matlab 
software and the results are summarized in tables (3.3), (3.4) below:  
Table (3.3):  LOO cross validation results. 
 
 
 
 
model No. 
descriptors 
PRESS SPRESS SST R
2
CV PRESS/S
ST 
PSE RSEP 
6 6 58.58 0.56 92.64 0.37 0.63 0.55 7.73 
7 7 55.91 0.55 95.31 0.41 0.59 0.54 7.55 
8 8 53.92 0.54 97.30 0.45 0.55 0.53 7.41 
9 7 54.52 0.54 96.70 0.44 0.56 0.53 7.45 
10 8 52.34 0.53 98.88 0.47 0.53 0.52 7.30 
11 9 50.53 0.53 100.69 0.50 0.50 0.51 7.18 
12 10 48.73 0.52 102.49 0.52 0.48 0.50 7.05 
13 11 47.08 0.51 104.14 0.55 0.45 0.50 6.93 
14 12 44.82 0.50 106.40 0.58 0.42 0.48 6.76 
15 13 43.11 0.49 108.11 0.60 0.40 0.47 6.63 
16 14 41.80 0.49 109.43 0.62 0.38 0.47 6.53 
17 15 40.32 0.48 110.90 0.64 0.36 0.46 6.41 
18 14 40.50 0.48 110.72 0.63 0.37 0.46 6.42 
19 15 38.89 0.47 112.33 0.65 0.35 0.45 6.29 
20 14 39.09 0.47 112.14 0.65 0.35 0.45 6.31 
21 15 37.75 0.46 113.48 0.67 0.33 0.44 6.20 
22 16 36.64 0.46 114.59 0.68 0.32 0.43 6.11 
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Table (3.4): LMO cross validation results 
model No. 
descriptors 
PRESS SPRESS SST R
2
CV PRESS/S
ST 
PSE RSEP 
6 6 55.95 0.55 93.92 0.40 0.60 0.54 7.54 
7 7 55.56 0.55 97.46 0.43 0.57 0.54 7.51 
8 8 54.99 0.55 101.13 0.46 0.54 0.54 7.47 
9 7 54.99 0.55 101.23 0.46 0.54 0.54 7.47 
10 8 54.60 0.55 103.70 0.47 0.52 0.53 7.45 
11 9 53.09 0.54 105.61 0.50 0.50 0.53 7.34 
12 10 52.52 0.54 108.17 0.51 0.49 0.52 7.30 
13 11 50.53 0.53 110.52 0.54 0.46 0.51 7.17 
14 12 47.86 0.52 108.57 0.56 0.44 0.50 6.97 
15 13 46.23 0.51 110.02 0.58 0.42 0.49 6.85 
16 14 45.60 0.51 111.73 0.59 0.41 0.49 6.81 
17 15 46.07 0.51 111.92 0.59 0.41 0.49 6.84 
18 14 45.70 0.51 110.51 0.59 0.41 0.49 6.81 
19 15 43.06 0.49 111.65 0.61 0.39 0.47 6.61 
20 14 42.44 0.49 110.69 0.62 0.38 0.47 6.57 
21 15 41.57 0.49 113.49 0.63 0.35 0.47 6.50 
22 16 41.57 0.48 113.94 0.64 0.36 0.47 6.50 
PRESS (predictive residual sum of squares) which is a standard index to measure the accuracy of the model. It is 
also called SSE (error sum of squares), SST (total sum of squares), R2cv (cross-validated correlation coefficient), 
SPRESS (uncertainty of prediction), PSE (Predictive Square Errors) and also called RMSE (root mean square 
error), and RSEP is relative standard error of prediction. 
From the results of LOO and LMO cross validation in tables (3.3) and (3.4) we can see that 
PRESS values always less than SST values and this means that the models predicting ability 
better than chance.   
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We use the values of PSE and R
2
CV in the tables to draw the following two graphs below. 
Figure (3.1) which is R
2
CV Vs model no. of both LOO & LMO, and figure (3.2) that shows 
PSE Vs model no. of both LOO & LMO. 


 
Figure (3.1): R
2
CV Vs model no. of both LOO & LMO 
 
 
Figure (3.2): PSE Vs model no. of both LOO & LMO



We can see from the values and the graphs that models (15-22) are the best models having the 
best validation parameters with the lowest values of PSE and highest values of R
2
CV. In both 
graphs we can see the slightly change in the curves from model 15 till model 22. So we picked 
those models as the best models to be the candidates to next steps, as inputs to PC-ANN and 
PLS.  
PC-ANN 
Before running ANN we applied PCA on the data to get rid of the inter correlation between 
descriptors, divide the descriptors into training, validation and test sets and get rid of outliers 
compounds that disturb the model. So we used the proper matlab script and apply it on a file 
that had the activity as the first column and all the descriptors of the picked models (15-22) as 
the other columns. The result of PCA application is shown in the figure (3.3) below, the graph 
shows the compounds disruption in the space of the first and the second principle components.       
Figure (3.3): correlation between 1
st
 and 2
nd
 principle components.


According to the above figure, compounds 125,128,129,155 are considered as outliers; outlier 
compounds are the compounds that lie far from the compounds cluster. This means that those 
four compounds act in different way from other compounds with respect to activity and 
descriptors. The other 188 compounds were partitioned into validation set 20%, test set 20% 
and the other 60% for training set. The compounds of each set were picked from the whole 
area of the compounds cluster. Those 188 compounds used as data points to ANN. 
PC-ANN models were built using the proper matlab scripts. We applied the script on each one 
of the picked models (15-22) using constant hidden nodes for all the models. The table (3.5) 
below shows a summary of the cross validation parameters of the models.  
Table (3.5): Correlation coefficient and cross validation parameters for ANN models (15-22). 
Mo 
no. 
nPCs R_tr PRESS
_tr 
R
2
CV_tr R_test PRESS 
_test 
RSEP 
_test 
R_val PRESS 
_val 
R2CV 
_val 
RSEP
_val 
15 6 0.810 32.86 0.29 0.76 13.85 8.52 0.67 13.67 -0.10 8.48 
16 6 0.817 31.00 0.42 0.75 14.00 8.57 0.72 11.77 0.14 7.87 
17 6 0.814 31.34 0.43 0.77 12.91 8.23 0.78 12.75 0.14 8.18 
18 7 0.841 27.50 0.50 0.78 12.89 8.22 0.71 12.12 0.10 7.98 
19 6 0.813 31.92 0.35 0.75 14.32 8.67 0.60 13.44 0.01 8.40 
20 7 0.828 29.46 0.44 0.75 14.03 8.58 0.76 10.67 0.31 7.49 
21 6 0.802 33.42 0.31 0.75 14.26 8.65 0.70 12.72 0.03 8.18 
22 7 0.825 29.84 0.44 0.75 14.10 8.60 0.73 11.44 0.25 7.75 
Mo: model.            
We used those values in the table above to draw several graphs to judge the results, and to 
choose the best models for the next step in ANN work.  
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Figure (3.4): correlation coefficient values against ANN model numbers. 
 
Figure (3.5): RSEP values of the test set against the model numbers.



Figure (3.6): R
2
CV values of the training set against the model numbers.
                             
Figure (3.7): PRESS values against the model numbers. 
The results are somehow regular. From figure (3.4), we can see that the model with the highest 
R of the test set is model 18, and the one after it is model 17, but when we compared the 
results according to R for the training set, model 18 is the highest but 20 is the one after, and 
the results aren’t the same according to R of the validation set model 20 is the best then model 
22. 
While when we look for figure (3.5) the models with the lowest RSEP values of the test set are 
18, 17. From figure (3.6): the models with the highest R
2
CV for the training set are 18, 22, and 
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20 respectively. At the same time, figure (3.7) shows that the models with the lowest PRESS 
values of the training set are 18, 20, and 22 respectively. 
Depending on the previous discussion we picked the models 18, 20, 17, and 22, to be the input 
for the next step to choose the best PC- ANN model. 
 Each one of those models was used to train the ANN model using different numbers of 
hidden nodes from (3-20). And we determined that we want R for the test set to be more than 
0.75.  The results of the four models are summarized in the tables (3.6), (3.7), (3.8), and (3.9). 
We take R-of the test set as our prior parameter to pick the best trial in each model because it 
reflects the predictivity of the models. 
 
Table (3.6): correlation coefficients and cross validation parameters of model 17.   
Hn 
no. 
nPCs  R_tr        PRESS_t
r      
R2CV_tr  R_test       PRESS_t
est   
RSEP_ 
test  
R_val           PRESS
_val    
RSEP
_ val   
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Hn no.: number of hidden nodes.  
With model 17 at 3 and 4 hidden nodes we did not get R of the test set more than 0.75 so I 
neglected the trials. The trail with the highest R of the test set is with 8 hidden nodes and by 
looking at all the parameters we notice that they are acceptable. So from this model we picked 
the trial with 8 hidden nodes to be compared with other models. 
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Table (3.7): correlation coefficients and cross validation parameters of model 18.   
Hn no. nPCs  R_tr 2        PRESS_tr  R2CV_tr  R_test        PRESS
_test   
RSEP_    
test  
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RSEP
_ val   
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Hn no.: number of hidden nodes.  
 
In model 18 the trail with 3 hidden nodes failed to reach 0.75 as R-test so the trial was 
neglected. In this model R-test of the trials with 6 and 16 hidden nodes are the best. We picked 
the trial with the 6 hidden nodes because of the risk of over fitting which increases with 
increasing the number of hidden nodes. And by looking at the other parameters in general, we 
notice that the trial with 6 hidden nodes better than that with 16 hidden nodes. 
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Table (3.8): correlation coefficients and cross validation parameters of model 20.   
Hn no.: number of hidden nodes.  
 
In model 20 the trails with 3 and 4 hidden nodes are neglected for the same reason as 
before. The trial with the best R-test is with 14 hidden nodes and the one after it is with 13 
hidden nodes. We preferred to pick the trial with 13 hidden nodes because the other 
parameters are better for this trial.     
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Table (3.9): correlation coefficients and cross validation parameters of model 22.   
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Hn no.: number of hidden nodes.  
 
With model 22 the one with best results as R test set is with 7 hidden nodes but it has R
2
CV of 
the training set equal to 0.5 and it must be greater than 0.5.  So there are the models with 13 
and 9 hidden nodes with good results of R-test and they have R
2
CV over than 0.5, we chose the 
trial with 9 hidden nodes because the over fitting risk with 13 hidden nodes. 
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We summarized the results of the hidden nodes optimization step in table (3.10) below.  
Table (3.10): Correlation coefficients and cross validation parameters of the optimal number 
of hidden nodes of each model. 
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RSE
P_ 
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Mo refers to: model. 
 Hn no.: number of hidden nodes.  
 
By gathering the best results, we found that Model 22 with 9 hidden nodes is the best with the 
highest R training, R test, R
2
 CV test, and lowest PRESS test set, RSEP test set, PRESS training 
set. But model 20 with 13 hidden nodes has higher R val, and lower RSEP val, PRESS val set, 
and accepted value of R
2
CV of training set over than 0.5. We can see that model 22 with 9 
hidden nodes and model 20 with 13 hidden nodes are the best with respect to correlation 
coefficients and cross validation parameters.  
Models 20 and 22 were examined to inspect the presence of outliers that may affect models 
validity.  By inspecting the residuals of these models there were no outliers as it is shown in 
figures (3.8) and (3.9). In both figures there is no compounds lie far from the compounds 
cluster in training, validation, and test set graphs.   
Figure (3.8) and figure (3.9)show regressions between observed and predicted activity as well 
as their residuals for the training, validation, and test sets for these two models. 

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Figure (3.8): Plot of the predicted activity against observed one as well as their residues for 
model 20 using 13 hidden nodes. (a) training set, (b) validation set, and (c) external test set. 



Figure (3.9):  Plot of the predicted activity against observed one as well as their residues for 
model 22 using 9 hidden nodes. (a) training set, (b) validation set, and (c) external test set. 
 Randomization 
The results for randomization test were performed to investigate the probability of chance 
correlation for the optimal models (20 with 13 hidden nodes and 22 with 9 hidden nodes).  
Tables (3.11) and (3.12) shows that the correlation coefficients obtained by chance are low in 
general while PRESS values are high. This indicates that the model obtained from PC-ANN is 
better than those obtained by chance.  
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
Table (3.11): The results of chance correlation of model 20 with 13 hidden. 
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Table (3.12): The results of chance correlation of model 22 with 9 hidden nodes. 
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And to ensure the robustness of the optimal models (20 with 13 hidden nodes and 22 with 9 
hidden nodes) we applied Y- randomization. The results are shown in table (3.13) below. And 
it’s obvious in the table that the correlation coefficients are lower than the results of the 
original models. This indicates that the developed models considered being robust enough. 
The values of cR
2
p are above 0.5 so both models are acceptable. (34) 
 
 



 Table (3.13): Values of correlation coefficients of randomized models and cR
2
p of the best 
PC-ANN models (20, 22): 
 
 
 
 
 
 
 
 
 
 
 
*Mo refers to: model, r refers to: randomized, R2: coefficient of determination, R2r: coefficient of    determination 
for randomized trial. 
** 

PLS 
PLS analysis with cross validation was carried out for advance investigation of the linear 
relationships of the obtained regression models. (Table 3.14) summarizes correlation 
coefficients and cross validation parameters for models 15-22 and also gathered with MLR 
and PC-ANN results. From this table, we can see that the PLS results are close to MLR results 
and better than PC-ANN results. Also, model 20 and 22 are the best according to PLS in 
which the correlation coefficient for the prediction set is 0.866 and 0.860 for these models 
Mo no.* R_train r*       R_train R
2
 r * R
2
 cR
2
p
**
 
Model 
20 
0.58 0.86 0.33 0.74 0.55 
Model 
22 
0.6 0.87 0.39 0.76 0.53 
 R_test  r *     R_test  
Model 
20 
0.07 0.78 0.01 0.60 0.60 
Model 
22 
0.12 0.78 0.02 0.61 0.60 


respectively. Also the root mean square error of prediction (RMSE 
p
) is 0.467 and 0.476 for 
model 20 and 22 respectively. 
Table (3.14):  Correlation coefficient for MLR, PLS and PC- ANN models (15-22) and cross 
 validation parameters obtained from PLS and PC- ANN analysis. 
 
C: calibration set: training set. 
P: Prediction set: test set. 
SE: Standard error. 
RMSE: root mean square error. 
 
 
Mod no. MLR  PC-ANN     PLS     
 R SE PC No. R
c
 R
2
CV 
c
 R 
p
 RMSE
p
 LV R
c
 R
2 
CV 
c
 R p RMSE
p
 
15 0.846 0.492 6 0.809 0.292 0.760 8.522 3 0.816 0.604 0.794 0.563 
16 0.851 0.486 6 0.817 0.420 0.753 8.570 3 0.823 0.616 0.793 0.564 
17 0.856 0.479 6 0.814 0.426 0.774 8.228 5 0.854 0.662 0.852 0.498 
18 0.856 0.478 7 0.841 0.498 0.776 8.222 4 0.847 0.645 0.846 0.497 
19 0.862 0.470 6 0.813 0.350 0.749 8.668 4 0.852 0.655 0.866 0.469 
20 0.861 0.470 7 0.828 0.442 0.753 8.579 4 0.851 0.656 0.866 0.467 
21 0.866 0.463 6 0.802 0.309 0.750 8.647 4 0.857 0.667 0.860 0.476 
22 0.870 0.458 7 0.825 0.440 0.752 8.601 4 0.861 0.670 0.860 0.476 
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Comparison with other QSAR studies: 
In the previous studies they used less number of compounds with limited cores, but in our 
study we used large number of VEGFR-2 compounds (192) with variety of cores to have a 
general QSAR model counting for the inhibitory activity in which we depend on large pool of 
descriptors (1497) not a particular class of them. MLR was applied and gave us good results 
with R
2
 = 0.758. To confirm our results, PC-ANN was applied too, in which R
2
= 0.681 which 
may be explained that the relation between the inhibitory activity (pIC50) and the structures is 
linear. In order to be convinced with this linear relation, PLS was applied and the results are 
even better than MLR in which R
2
= 0.741 and R
2
cv = 0.670. Regarding previous studies, in 
2009 comparative molecular field analysis (CoMFA) and comparative molecular similarity 
indices analysis (CoMSIA) were performed on a series of selective inhibitors of VEGFR-2 (82 
compounds). The best CoMFA and CoMSIA models gave a cross-validated coefficient R
2
cv 
of 0.546 and 0.715 respectively (6). 
In 2010 Simultaneous optimization has been proposed and evaluated on a set of novel 
VEGFR-2 inhibitors including naphthalene and indazole-based compounds (61 compounds). 
The final support vector regression model was constructed on an optimal set of six descriptors. 
The results are R
2
 (0.908, 0.837) for 45 training and 16 test samples. It is clear that number of 
compounds is small in comparison to our study (7). 
In 2011 3D-QSAR technique was carried out on diaryl acylsulfonamide derivatives as 
VEGFR-2 inhibitors by using Comparative Molecular Field Analysis (CoMFA) studies to find 
relations between biological activities of inhibitors and their structures. 3DQSAR technique 
was applied to a set of fifty ligands in order to facilitate the design of more potent inhibitors. 
The maximum cross-validated correlation coefficient value was found to be 0.417 (36). 
In 2011 two 3D-QSAR models were built using CoMFA and CoMSIA methods, using 80 
compounds of indolocarbazole series as VEGFR-2 inhibitors. The two QSAR models with 
highest predictabilities obtained were (CoMFA model: R
2
cv = 0.823, R
2
 = 0.979; CoMSIA 
model: R
2
cv = 0.804, R
2
 = 0.967). (37) 
Another study (38) developed a nonlinear model for the inhibition activities for a set of 
pyrazine-pyridine biheteroaryls, inhibitors of Vascular Endothelial Growth Factor Receptor-2 
(VEGFR-2) based on Least Squares Support Vector Machines (LSSVMs). Five relevant 
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descriptors selected by heuristic method were used to build linear and nonlinear QSAR models 
using MLR and LS-SVMs. The nonlinear LS-SVMs model gave the correlation coefficients of 
0.921 and the MSE of 0.046 for the training set. The corresponding correlation coefficient and 
MSE for the test set are 0.877 and 0.041, respectively. 
These results have been accepted for publication in the journal: Current Pharmaceutical 
Design (39). 
 
 

 
 
 


 
Chapter Four 
Conclusion 
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To study the inhibitory activity of vascular endothelial growth factor receptor-2 (VEGFR-2), 
the structures of 192 compounds were built using Hyperchem software. Those structures were 
optimized using AM1 semi-imperical method.  We calculated different groups of descriptors, 
some descriptors were calculated using Hyperchem software and others were calculated using 
Dragon software. 
SPSS software was used to get the multiple linear QSAR equations. We obtained eight 
multiple linear equations with good statistical qualities and predictive power. Those equations 
were used as input to PC-ANN modeling. The best four PC-ANN models were used for 
hidden nodes optimization. The cross validation results of PC-ANN models were not better 
than MLR as expected, so we decided to perform PLS analysis to confirm the linearity of the 
relationship. The eight MLR equations were used as PLS input. The PLS gives improved 
regression models with better prediction ability compared with PC-ANN. 
The most important descriptors in this relation are G2s and G2u which reflect the molecular 
geometrical coordinates of the compounds; G2s is inversely proportional to the inhibitory 
activity of the compounds while G2u is directly proportional to the inhibitory activity of the 
compounds. PLS based models are quite good to describe the QSAR of the VEGFR-2 for the 
data set in this investigation. A 0.866 and 0.860 correlation coefficients were obtained for the 
best two models using PLS with 4 LV
s. 
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